Zemin Cao

4.0k total citations
53 papers, 3.4k citations indexed

About

Zemin Cao is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Zemin Cao has authored 53 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 18 papers in Molecular Biology and 16 papers in Nephrology. Recurrent topics in Zemin Cao's work include Renin-Angiotensin System Studies (25 papers), Chronic Kidney Disease and Diabetes (13 papers) and Hormonal Regulation and Hypertension (13 papers). Zemin Cao is often cited by papers focused on Renin-Angiotensin System Studies (25 papers), Chronic Kidney Disease and Diabetes (13 papers) and Hormonal Regulation and Hypertension (13 papers). Zemin Cao collaborates with scholars based in Australia, United States and Japan. Zemin Cao's co-authors include Mark E. Cooper, Terri J. Allen, Riccardo Candido, Fabrice Bonnet, Josephine M. Forbes, Karin Jandeleit‐Dahm, Wendy C. Burns, Mark E. Cooper, Markus Lassila and Hiroshi Kawachi and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Circulation Research.

In The Last Decade

Zemin Cao

52 papers receiving 3.3k citations

Peers

Countries citing papers authored by Zemin Cao

Since Specialization

Citations

This map shows the geographic impact of Zemin Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zemin Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zemin Cao more than expected).

Fields of papers citing papers by Zemin Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zemin Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zemin Cao. The network helps show where Zemin Cao may publish in the future.

Co-authorship network of co-authors of Zemin Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Zemin Cao. A scholar is included among the top collaborators of Zemin Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zemin Cao. Zemin Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Honokiol rescues progranulin deficiency in pathogen-induced and genetically driven neurodegeneration: Bridging veterinary models with therapeutic development 2025 ·Veterinary Microbiology ·Zemin Cao, Wenqi He, (unknown), (unknown), (unknown), Feng Gao, Yungang Lan	0
2	Cell division autoantigen 1 enhances signaling and the profibrotic effects of transforming growth factor-β in diabetic nephropathy 2010 ·Kidney International ·(unknown), Tieqiao Wu, Aozhi Dai, (unknown), Phyllis Chew, Judy B. de Haan, Yu Wang, Ban‐Hock Toh, Hong‐Jian Zhu, Zemin Cao, Mark E. Cooper, Zhonglin Chai	27
3	Antiproliferative Autoantigen CDA1 Transcriptionally Up-regulates p21Waf1/Cip1 by Activating p53 and MEK/ERK1/2 MAPK Pathways 2007 ·Journal of Biological Chemistry ·(unknown), (unknown), Tieqiao Wu, Zemin Cao, Richard J. Wilkins, Ban Hock Toh, Mark E. Cooper, Zhonglin Chai	62
4	Interactions between Renin Angiotensin System and Advanced Glycation in the Kidney 2005 ·Journal of the American Society of Nephrology ·Merlin C. Thomas, Christos Tikellis, W. Burns, (unknown), Zemin Cao, Melinda T. Coughlan, (unknown), Mark E. Cooper, Josephine M. Forbes	110
5	Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes 2004 ·Kidney International ·Guorong Ma, Terri J. Allen, Mark E. Cooper, Zemin Cao	26
6	Interactions between Angiotensin II and NF-κB–Dependent Pathways in Modulating Macrophage Infiltration in Experimental Diabetic Nephropathy 2004 ·Journal of the American Society of Nephrology ·(unknown), Zemin Cao, David M. Long, Sianna Panagiotopoulos, George Jerums, Mark E. Cooper, Josephine M. Forbes	136
7	Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes 2003 ·Kidney International ·Jie Qin, Zhili Zhang, Jie Liu, (unknown), Ling Hu, Mark E. Cooper, Zemin Cao	40
8	Reduced tubular cation transport in diabetes: Prevented by ACE inhibition 2003 ·Kidney International ·Merlin C. Thomas, Chris Tikellis, Wendy C. Burns, Vicki Thallas, Josephine M. Forbes, Zemin Cao, Tanya M. Osicka, Leileata M. Russo, George Jerums, Hany Ghabrial, Mark E. Cooper, Phillip Kantharidis	47
9	Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy 2003 ·Diabetologia ·Belinda J. Davis, C. I. Johnston, Louise M. Burrell, Wendy C. Burns, Eiji Kubota, Zemin Cao, M. E. Cooper, Terri J. Allen	55
10	Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria 2002 ·Journal of Hypertension ·Josephine M. Forbes, Fabrice Bonnet, Leileata M. Russo, Wendy C. Burns, Zemin Cao, Riccardo Candido, Hiroshi Kawachi, Terri J. Allen, Mark E. Cooper, George Jerums, Tanya M. Osicka	77
11	Increased Osteopontin Expression following Renal Ablation Is Attenuated by Angiotensin Type 1 Receptor Antagonism 2002 ·Nephron Experimental Nephrology ·Zemin Cao, Alison J. Cox, Fabrice Bonnet	4
12	Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases 2002 ·Diabetologia ·Sue McLennan, Darren J. Kelly, Alison J. Cox, Zemin Cao, J. Guy Lyons, Dennis K. Yue, (unknown)	110
13	Angiotensin Type 2 Receptor Antagonism Confers Renal Protection in a Rat Model of Progressive Renal Injury 2002 ·Journal of the American Society of Nephrology ·Zemin Cao, Fabrice Bonnet, Riccardo Candido, (unknown), Wendy C. Burns, Hiroshi Kawachi, Fujio Shimizu, Robert M. Carey, Marc de Gasparo, Mark E. Cooper	102
14	Renal expression of angiotensin receptors in long-term diabetes and the effects of angiotensin type 1 receptor blockade 2002 ·Journal of Hypertension ·Fabrice Bonnet, Riccardo Candido, Robert M. Carey, David Casley, Leileata M. Russo, Tanya M. Osicka, Mark E. Cooper, Zemin Cao	37
15	Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion 2001 ·Journal of Hypertension ·Fabrice Bonnet, Mark E. Cooper, Robert M. Carey, David Casley, Zemin Cao	54
16	Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats 2001 ·Kidney International ·Zemin Cao, Louise M. Burrell, Ilkka Tikkanen, Fabrice Bonnet, Mark E. Cooper, Richard E. Gilbert	77
17	Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis 2000 ·Kidney International ·Zemin Cao, Darren J. Kelly, Alison J. Cox, David Casley, Josephine M. Forbes, Paul Martinello, Rachael Dean, Richard E. Gilbert, Mark E. Cooper	116
18	Attenuation of diabetes-associated mesenteric vascular hypertrophy with perindopril: Morphological and molecular biological studies 1998 ·Metabolism ·Mark E. Cooper, Zemin Cao, Jonathan R. Rumble, Karin Jandeleit, Terri J. Allen, Richard E. Gilbert	16
19	Angiotensin converting enzyme inhibition and calcium antagonism attenuate streptozotocin-diabetes-associated mesenteric vascular hypertrophy independently of their hypotensive action 1998 ·Journal of Hypertension ·Zemin Cao, U. Lennart Hulthén, Terri J. Allen, Mark E. Cooper	18
20	Renal amylin binding in normotensive and hypertensive rats 1997 ·Journal of Hypertension ·Zemin Cao, Peter J. Wookey, Leonard L. Wu, Michiel Voskuil, Rutger C. I. van Geenen, Mark E. Cooper	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact